Trial Profile
Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Encaleret (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Japan Tobacco
- 03 Jun 2016 New trial record